Galectin-3 controls the severity of inflammation and induces the activation of NLRP3 inflammasome-dependent pathways in Huntington's disease and spinal cord injuries (Ren et al., 2019; Siew et al., 2019). This evidence concerns the gene NLRP3 and juvenile Huntington disease.